Jul 16, 2026 Corporate Kitazato Exhibits Its Largest-Ever Booth at ESHRE 2026, the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology Kitazato Corporation (“Kitazato” or “the Company”) exhibited at ESHRE 2026, the 42nd Annual Meeting of the European Society of Human Reproduction and Embryology, one of the world’s largest conferences in the field of reproductive medicine, held in London, United Kingdom, 5-8 July 2026. Kitazato provides media, and consumables or fertility treatment worldwide. The Company offers products used throughout the fertility treatment process, from oocyte retrieval and sperm collection to washing, culture, fertilization and cryopreservation. In the field of cryopreservation in particular, Kitazato’s technologies are used in clinical settings in more than 110 countries, contributing to the standardization of assisted reproductive technologies across the globe. Kitazato’s booth As a Superior Sponsor of ESHRE 2026, Kitazato exhibited its largest-ever booth in the center of the exhibition hall. During the conference, numerous healthcare professionals and researchers around the world were welcomed at the booth. Together with its distributors from different countries, Kitazato introduced its products and provided information to visitors. The products showcased at the booth included media “Ultra-Fast® Vitri / Warm”, which reduces the time required for oocyte / embryo vitrification by approximately 80% and warming by approximately 90% compared with conventional protocols, as well as HypureOil® Plus, a paraffin oil for embryo culture designed to suppress increases in peroxide value (POV). These products attracted significant interest from visitors. Ignacio Bermejo, Director; Maki Ogawa, Director; Futoshi INOUE, President (from left) At ESHRE 2026, numerous physicians and researchers presented research findings involving the use of Kitazato products, including Cryotop® and the Company’s vitrification / warming media. These presentations provided another valuable opportunity to confirm that Kitazato products are widely used in clinical and research settings around the world. Kitazato extends its sincere appreciation to all those who presented research findings using its products and to everyone who visited the Company’s booth. Kitazato will continue striving to further enhance the quality of its products and services to contribute to the advancement of reproductive medicine and related research. Back to News List
